Effectiveness of Riboflavin-Moxifloxacin Amniotic Membrane as an Adjuvant for PACK-CXL in Moderate to Severe Infectious Keratitis

NCT07559149 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Infected Corneal Ulcers
CXL

Interventions

COMBINATION_PRODUCT: Riboflavin-Moxifloxacin Amniotic Membrane
OTHER: Standard PACK-CXL

Sponsor

Gadjah Mada University